Executive Summary
Acute myeloid leukemia (AML) is a disorder that generally produces neutrophils, red blood cells, or platelets, which are types of healthy blood cells. It begins in the bone marrow (the soft inner part of bones, where new blood c...
Executive Summary
Childhood Acute Myeloid Leukemia is the most common cancer in children. It is the second most common form of leukemia in children after acute lymphoblastic leukemia. Childhood AML is expected during the first two and teenage yea...
Executive Summary
Risk factors influence the chance of developing cancer (childhood acute myeloid leukemia) among individuals, but individuals with no risk factors also develop cancer. Although the cause of childhood AML is unknown, some factors ...
Executive Summary
Studies are still evaluating the factors accountable for causing childhood acute myeloid leukemia, thereby devising ways to prevent these diseases. Since most people having AML don’t have risk factors that can change, there is...
Executive Summary
Childhood acute myeloid leukemia is diagnosed based on its symptoms. So, the signs and symptoms of the childhood AML experienced by the individuals help describe a medical problem. The early symptoms are similar to flu or other ...
Executive Summary
Several diagnostic tests helps in determining childhood acute myeloid leukemia. The main procedures to diagnose childhood acute myeloid leukaemia are a patient’s medical history, complete blood cell count, physical examination...
Executive Summary
Childhood acute myeloid leukaemia classification depends upon their similarity with healthy immature bone marrow blast cells and genetic and molecular testing of the leukaemia cells. Childhood AML consists of eight major subtype...
Executive Summary
Treatment (childhood acute myeloid leukemia) recommendations depend upon the patient’s state of Acute Myeloid Leukemia. Treatments recommendations depend on the size, grade and type of tumor, metastasis, possible side effects,...
Executive Summary
Clinical trials are considered a better method for treating childhood acute myeloid leukemia. The evaluation of new drugs, different combinations of treatments, new approaches to surgery, and new therapies are a part of the clin...
Executive Summary
Several latest research studies are underway to seek more information on childhood acute myeloid leukemia. The various related prevention methods, diagnostic process at the initial phase, and best treatment strategies. Genetic t...
Executive Summary
Treatments of childhood acute myeloid leukemia result in causing various side effects and changes to the patient’s body. The results of treatment show variations among the patients. And so, the same treatment strategy used for...
Executive Summary
Follow-up care for childhood acute myeloid leukemia refers to the after-treatment protocols conducted by the healthcare team to look after recurrence, manage the side effects, and monitor the patients’ overall health. The foll...
Executive Summary
Survivorship begins after the disease (childhood acute myeloid leukemia) is diagnosed. People who have been taking treatments and whose disease condition has been cured post-treatment are also considered survivors. Cancer surviv...
When making up your mind about treatment, you must know every detail about the treatment you opt for. It would be best to ask questions about anything about cancer that you don't understand.
Don't forget to ask the healthcare team questions durin...
Here are a few links -
https://www.cancer.net/cancer-types/leukemia-acute-myeloid-aml-childhoodhttps://www.cancer.gov/types/leukemia/patient/child-aml-treatment-pdqhttps://www.nhsinform.scot/illnesses-and-conditions/cancer/cancer-types-in-child...
